1.Neuroendocrine differentiation in prostate cancer.
Cheng-yu WU ; Yan-qun NA ; Jorge L YAO ; P Anthony di SANT'AGNESE ; Jiao-ti HUANG
Chinese Journal of Pathology 2006;35(9):565-567
Animals
;
Carcinoma, Neuroendocrine
;
metabolism
;
pathology
;
physiopathology
;
Carcinoma, Small Cell
;
metabolism
;
pathology
;
physiopathology
;
Cell Differentiation
;
Chromogranin A
;
metabolism
;
Humans
;
Male
;
Neuroendocrine Cells
;
metabolism
;
pathology
;
Prostatic Neoplasms
;
metabolism
;
pathology
;
physiopathology
2.Neuroendocrine cells of prostate cancer: biologic functions and molecular mechanisms.
Yu-Hua HUANG ; Ya-Qun ZHANG ; Jiao-Ti HUANG
Asian Journal of Andrology 2019;21(3):291-295
Prostate cancer (PCa) is a major health risk for older men worldwide. Existing systemic therapies mostly target androgen receptor (AR). Although treatments are initially effective, the disease always recurs. A potential mechanism for the treatment failure is that PCa contains, in addition to the AR-positive luminal type tumor cells, a small component of neuroendocrine (NE) cells. The function of NE cells in PCa remains poorly understood, and one important characteristic of these cells is their lack of expression of AR and resistance to hormonal therapy. In addition, many patients develop the more aggressive small-cell neuroendocrine carcinoma (SCNC) after hormonal therapy. Although this clinical phenomenon of disease transformation from adenocarcinoma to SCNC is well established, the cell of origin for SCNC remains unclear. Recently, loss of function of Rb and TP53 and amplification and overexpression of MYCN and Aurora A kinase have been identified as important biomarkers and potential disease drivers. In this article, we systematically review the histology of normal prostate and prostate cancer including the main histologic types: adenocarcinoma and SCNC. We also review the findings from many studies using cellular and animal models as well as human specimens that attempt to understand the molecular mechanisms of treatment failure, disease progression, and tumor transformation from adenocarcinoma to SCNC.
Adenocarcinoma/pathology*
;
Carcinoma, Small Cell/pathology*
;
Humans
;
Male
;
Neuroendocrine Cells/pathology*
;
Prostatic Neoplasms/pathology*
3.The evaluation of training program "resident team leader in the Department of General Internal Medicine" at Peking Union Medical College Hospital
Yang JIAO ; Min SHEN ; Xiaoming HUANG ; Hongwei FAN ; Xuejun ZENG ; Fengchun ZHANG ; Ti SHEN
Chinese Journal of Internal Medicine 2019;58(6):435-438
Objective To evaluate senior resident training program "resident team leader in the Department of General Internal Medicine" at Peking Union Medical College Hospital.Methods We surveyed the residents or the fellows who had been selected as resident team leaders and received the training from October 2014 to September 2018 on their comments and suggestions.Results Twenty-two rotated senior residents who were selected as team leaders in the Department of General Internal Medicine completed the survey.Almost all(21/22,95.5%) of the respondents reported that they learnt more in general as team leaders by Visual Analog Scale (VAS).The mean VAS scores of clinical skills were 7.23±1.27,7.86± 1.32 in teaching abilities,8.14±0.89 in leadership evaluation.Scales as chief resident assistants were 8.44± 1.26.Sixteen respondents (72.7%)considered that pre-job training by attending doctors was necessary.Another 8 (36.4%)respondents addressed their demands on training of teaching skills.Conclusions The senior resident training program "resident team leader in the Department of General Internal Medicine" improves the competency of rotated senior residents.It is a valuable pilot study on senior resident training and worthy of further application in other departments and hospitals.
4.Effect of origin, tree age, and harvesting time on content of flavonoids and terpene lactones in Ginkgo Folium.
Fu-Juan SHI ; Chao-Jie YANG ; Xiu-Fen CHEN ; Mi-Ji-Ti MAIHELIYA ; Miao-Miao HUANG ; Xue-Jiao WEI ; Kun WANG ; Chun-Sheng LIU ; Yao-Jun YANG
China Journal of Chinese Materia Medica 2022;47(15):4055-4065
The content of total flavonol glycosides in Ginkgo Folium in the planting bases was determined by high performance liquid chromatography(HPLC).The samples were extracted by reflux with methanol-25% hydrochloric acid.The HPLC conditions were as follows: Agilent ZORBAX SB-C_(18) column(4.6 mm×250 mm, 5 μm), isocratic elution with mobile phase of 0.4% phosphoric acid solution-methanol(45∶55), flow rate of 1 mL·min~(-1), column temperature of 30 ℃, detection wavelength of 360 nm, and injection vo-lume of 10 μL.A method for the determination of terpene lactones in Ginkgo Folium was established based on ultra-high performance liquid chromatograph-triple-quadrupole/linear ion-trap tandem mass spectrometry(UPLC-QTRAP-MS/MS).The UPLC conditions were as below: gradient elution with acetonitrile-0.1% formic acid, flow rate of 0.2 mL·min~(-1), column temperature of 30 ℃, sample chamber temperature of 10 ℃, and injection volume of 10 μL.The ESI~+and multiple reaction monitoring(MRM) were adopted for the MS.The above methods were used to determine the content of total flavonol glycosides and terpene lactones in 99 batches of Ginkgo Folium from 6 planting bases, and the results were statistically analyzed.The content of flavonoids and terpene lactones in Ginkgo Folium from different origins, from trees of different ages, harvested at different time, from trees of different genders, and processed with different methods was compared.The results showed that the content of total flavonol glucosides in 99 Ginkgo Folium samples ranged from 0.38% to 2.08%, and the total content of the four terpene lactones was in the range of 0.03%-0.87%.The method established in this study is simple and reliable, which can be used for the quantitative analysis of Ginkgo Folium.The research results lay a basis for the quality control of Ginkgo Folium.
Chromatography, High Pressure Liquid/methods*
;
Flavonoids/analysis*
;
Flavonols
;
Ginkgo biloba
;
Glycosides/analysis*
;
Lactones/analysis*
;
Methanol
;
Plant Leaves/chemistry*
;
Tandem Mass Spectrometry/methods*
;
Terpenes/analysis*
;
Trees
5.A retrospective controlled study of TACE-HAIC-targeted-immune quadruple therapy for intermediate and advanced-stage hepatocellular carcinoma.
Ling LI ; Jian HE ; Yi Xing XIE ; Xin Hui HUANG ; Xia Ti WENG ; Xin Ting PAN ; Yu Bing JIAO ; Hang Hai ZHENG ; Lin Bin QIU ; Wu Hua GUO
Chinese Journal of Hepatology 2022;30(9):939-946
Objective: To evaluate the efficacy and safety of transcatheter arterial chemoembolization (TACE)-hepatic arterial infusion chemotherapy (HAIC)-targeted-immune quadruple therapy in patients with intermediate and advanced-stage hepatocellular carcinoma (HCC). Methods: 101 patients with intermediate and advanced stage HCC were enrolled according to the inclusion and exclusion criteria, and then they were divided into a combination group and a control group. Patients in the combination group was treated with TACE-HAIC-targeted-immune quadruple therapy, while the control group was only treated with TACE therapy. The overall survival (OS), progression-free survival (PFS), and treatment-related adverse reactions were statistically analyzed in the two groups of patients. Statistical analysis was carried out by t-test, χ2 test, rank sum test, Kaplan-Meier curve, log-rank test, Cox regression (or proportional hazards model) analysis according to different data. Results: The tumor objective response rate and disease control rate as evaluated by mRECIST 1.1 criteria in the combination group were 80% and 94%, respectively, which were significantly higher than those in the control group, 41.2% (P<0.001) and 74.5% (P=0.007). The OS and PFS of the combination group were 15.6 months [95%CI 11.3-NA ] and 8.8 months [95%CI 6.9-12.0], respectively, which were significantly better than the control group at 6.1 months [95%CI 5.3-6.6] (P<0.001) and 3.2 months [95%CI 3.0-3.6] (P<0.001). Gastric ulcer incidence was significantly higher in the combination group (9/50, 18%) than that in the control group (2/51, 3.9%) (P=0.023). Conclusion TACE-HAIC-targeted-immune quadruple therapy is a more effective treatment mode for intermediate and advanced-stage HCC than TACE alone, and attention should be paid to the monitoring of target immune-related adverse reactions.
Humans
;
Carcinoma, Hepatocellular/pathology*
;
Chemoembolization, Therapeutic
;
Liver Neoplasms/pathology*
;
Retrospective Studies
;
Infusions, Intra-Arterial
;
Treatment Outcome